YC S18
CB Therapeutics
Fermentation-derived natural products to solve health problems
About
CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.
Founders
- Sher Butt
- Jacob Vogan
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in CB Therapeutics.
See family office activityIndustry & Focus
HealthcareIndustrial BioCellular AgricultureBiotech